{"Title": "A Human IPS Model Implicates Embryonic B-Myeloid Fate Restriction as Developmental Susceptibility to B Acute Lymphoblastic Leukemia-Associated ETV6-RUNX1", "Year": 2018, "Source": "Dev. Cell", "Volume": "44", "Issue": 3, "Art.No": null, "PageStart": 362, "PageEnd": null, "CitedBy": 19, "DOI": "10.1016/j.devcel.2017.12.005", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85044733881&origin=inward", "Abstract": "\u00a9 2017 The Author(s)ETV6-RUNX1 is associated with childhood acute B-lymphoblastic leukemia (cALL) functioning as a first-hit mutation that initiates a clinically silent pre-leukemia in utero. Because lineage commitment hierarchies differ between embryo and adult, and the impact of oncogenes is cell-context dependent, we hypothesized that the childhood affiliation of ETV6-RUNX1 cALL reflects its origins in a progenitor unique to embryonic life. We characterize the first emerging B cells in first-trimester human embryos, identifying a developmentally restricted CD19\u2212IL-7R+ progenitor compartment, which transitions from a myeloid to lymphoid program during ontogeny. This developmental series is recapitulated in differentiating human pluripotent stem cells (hPSCs), thereby providing a model for the initiation of cALL. Genome-engineered hPSCs expressing ETV6-RUNX1 from the endogenous ETV6 locus show expansion of the CD19\u2212IL-7R+ compartment, show a partial block in B lineage commitment, and produce proB cells with aberrant myeloid gene expression signatures and potential: features (collectively) consistent with a pre-leukemic state. B\u00f6iers, Richardson et al. explore the potential for a developmental susceptibility to childhood acute lymphoblastic leukemia. Characterization of earliest B cell progenitors in human fetal liver identified a unique progenitor compartment that can be recapitulated using human pluripotent stem cells to model the impact of the pre-leukemia-initiating oncogene ETV6-RUNX1.", "AuthorKeywords": ["acute lymphoblastic leukemia", "B cell", "CRISPR/Cas9", "ETV6-RUNX1", "genome engineering", "human fetal lymphopoiesis", "human pluripotent stem cells", "in vitro B cell differentiation"], "IndexKeywords": ["Acute Disease", "B-Lymphocytes", "Core Binding Factor Alpha 2 Subunit", "Embryonic Development", "Female", "Gene Expression Regulation, Leukemic", "Humans", "Induced Pluripotent Stem Cells", "Models, Biological", "Myeloid Cells", "Oncogene Proteins, Fusion", "Precursor Cell Lymphoblastic Leukemia-Lymphoma", "Pregnancy", "Pregnancy Trimester, First", "Receptors, Interleukin-7", "Transcriptome"], "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 1, "EID": "2-s2.0-85044733881", "SubjectAreas": [["Molecular Biology", "BIOC", "1312"], ["Biochemistry, Genetics and Molecular Biology (all)", "BIOC", "1300"], ["Developmental Biology", "BIOC", "1309"], ["Cell Biology", "BIOC", "1307"]], "AuthorData": {"14321144000": {"Name": "B\u00f6iers C.", "AuthorID": "14321144000", "AffiliationID": "60118986, 60029170", "AffiliationName": "Lund Stem Cell Center, Lund University"}, "57207713218": {"Name": "Richardson S.E.", "AuthorID": "57207713218", "AffiliationID": "60109234, 60022148", "AffiliationName": "Department of Cancer Biology, UCL Cancer Institute, UCL"}, "57201426386": {"Name": "Laycock E.", "AuthorID": "57201426386", "AffiliationID": "60109234, 60022148", "AffiliationName": "Department of Cancer Biology, UCL Cancer Institute, UCL"}, "57192307908": {"Name": "Turati V.A.", "AuthorID": "57192307908", "AffiliationID": "60109234, 60022148", "AffiliationName": "Department of Cancer Biology, UCL Cancer Institute, UCL"}, "55605766350": {"Name": "Brown J.", "AuthorID": "55605766350", "AffiliationID": "60109234, 60022148", "AffiliationName": "Department of Cancer Biology, UCL Cancer Institute, UCL"}, "24333414500": {"Name": "Wray J.P.", "AuthorID": "24333414500", "AffiliationID": "60109234, 60022148", "AffiliationName": "Department of Cancer Biology, UCL Cancer Institute, UCL"}, "57198728898": {"Name": "Wang D.", "AuthorID": "57198728898", "AffiliationID": "60109234, 60022148", "AffiliationName": "Department of Cancer Biology, UCL Cancer Institute, UCL"}, "57203032477": {"Name": "James C.", "AuthorID": "57203032477", "AffiliationID": "60109234, 60022148", "AffiliationName": "Department of Cancer Biology, UCL Cancer Institute, UCL"}, "23477304600": {"Name": "Herrero J.", "AuthorID": "23477304600", "AffiliationID": "60109234, 60022148", "AffiliationName": "Department of Cancer Biology, UCL Cancer Institute, UCL"}, "7006621281": {"Name": "Enver T.", "AuthorID": "7006621281", "AffiliationID": "60118986, 60029170", "AffiliationName": "Lund Stem Cell Center, Lund University"}, "55515990000": {"Name": "Zriwil A.", "AuthorID": "55515990000", "AffiliationID": "60118986, 60029170", "AffiliationName": "Lund Stem Cell Center, Lund University"}, "56045941400": {"Name": "Sitnicka E.", "AuthorID": "56045941400", "AffiliationID": "60118986, 60029170", "AffiliationName": "Lund Stem Cell Center, Lund University"}, "57189813589": {"Name": "Karlsson S.", "AuthorID": "57189813589", "AffiliationID": "60118986, 60029170", "AffiliationName": "Lund Stem Cell Center, Lund University"}, "16455497700": {"Name": "Smith A.J.H.", "AuthorID": "16455497700", "AffiliationID": "60026851, 60016410", "AffiliationName": "MRC Molecular Haematology Unit, University of Oxford"}, "8079382800": {"Name": "Jacobsen S.E.W.", "AuthorID": "8079382800", "AffiliationID": "60019295", "AffiliationName": "Karolinska University Hospital"}}}